To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill provides xylazine detection and analysis and creates study on United States Government technologies and analytical methods to detect and identify new psychoactive substances The Comptroller General of the United States shall conduct a study of the capabilities. It relies on reporting requirements, definition changes, appropriations, and tax rate changes. The main policy areas are Education, Healthcare, Transportation, and Housing.
Who Benefits and How
Transportation operators and users affected by the bill could face lower compliance burdens, Patients and health care consumers affected by the bill could face lower compliance burdens, and Homeowners, tenants, or housing market participants affected by the bill could face lower compliance burdens.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties.
Key Provisions
- Provides xylazine detection and analysis.
- Creates study on United States Government technologies and analytical methods to detect and identify new psychoactive substances The Comptroller General of the United States shall conduct a study of the capabilities...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill provides xylazine detection and analysis and creates study on United States Government technologies and analytical methods to detect and identify new psychoactive substances The Comptroller General of the United States shall conduct a study of the capabilities.
Key Policy Areas
Education, Healthcare, Transportation, Housing
Primary Purpose
The bill provides xylazine detection and analysis and creates study on United States Government technologies and analytical methods to detect and identify new psychoactive substances The Comptroller General of the United States shall conduct a study of the capabilities.
Policy Domains
Whole bill
Identified Gains
- Transportation operators and users affected by the bill
- Patients and health care consumers affected by the bill
- Homeowners, tenants, or housing market participants affected by the bill
- Educational institutions and students affected by the bill
- Researchers and scientific institutions affected by the bill
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
Sponsors
Legislative Progress
IntroducedMr. Cruz (for himself and Mr. Welch) introduced the following …
Mr. Cruz (for himself, Mr. Welch, Mrs. Capito, Mr. Warnock, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology